Entera Bio Ltd expected to post a loss of 12 cents a share - Earnings Preview

Entera Bio

16/08/2021 04:50

* Entera Bio Ltd  ENTX.OQ   ENTX.O  is expected to show a rise
in quarterly revenue when it reports results on August 16. 
* The Jerusalem, Israel-based company is expected to report   a
66.3% increase in revenue to $86.5 thousand from $52 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Entera Bio Ltd is for a
loss of 12 cents per share. For the same quarter last year, the
company reported a loss of 17 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Entera Bio Ltd
is $12​, about 55% above​ its last closing price of $5.40. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.12       -0.12      -0.11     Beat    8.3
 Dec. 31 2020  -0.14       -0.14      -0.13     Beat    7.1
 Sep. 30 2020  -0.20       -0.20      -0.09     Beat    55​
 Jun. 30 2020  -0.12       -0.12      -0.17     Missed  -41.7
 ​​            ​                                        ​
                                                        ​
 Sep. 30 2019  -0.15       -0.15      -0.25     Missed  -66.7
 Jun. 30 2019  -0.28       -0.28      -0.12     Beat    57.1
 This summary was machine generated August 16 at 03:50 GMT.  All
figures in US dollars unless otherwise stated